For submission details, please reach out to the respective local affiliate in the country where you are living. You can find contact details here
We support observational studies where research is measured according to standard of care, without any attempt to change or intervene. Data can be obtained through secondary use of data (e.g., claims data, medical chart review, electronic healthcare records, meta-analyses, etc.).
We support interventional drug research which processes data derived from humans or human specimens. Support of study drug must come from the NNI ISS Program.
Novo Nordisk understands that ideas may arise that represent “out of the box thinking,” and are ultimately of great interest to our organization. We welcome these ideas for submission. Please email your affiliate contact to determine alignment of your idea with organizational areas of interest.
The Novo Nordisk teams strive to provide timely responses to all applications. Specific timings for review vary based on volume of protocols submitted and nature of the protocols.
For additional questions please speak with your local affiliate contact.